Clinical Trial Update: Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial of Capecitabine plus Y-90 radioembolization for advanced intrahepatic cholangiocarcinoma (bile duct cancer) that cannot be surgically removed ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Yttrium-90 radioembolization microspheres (SIR-Spheres) (yttrium-90 microspheres)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Bile Duct Adenocarcinoma, Stage III Intrahepatic Cholangiocarcinoma | Phase 1 | Status: WITHDRAWN